Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications

References

• Pauwels RA, Rabe KF. Burden and clinical features of chronicobstructive pulmonary disease (COPD). Lancet 2004;364:613–20
   PubMed Web of Science ®Google Scholar
• Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructivelung disease and low lung function in adults in the United States:data from the National Health and Nutrition ExaminationSurvey, 1988–1994. Arch Intern Med 2000;160:1683–9
   PubMed Web of Science ®Google Scholar
• Petty TL, Weinmann GG. Building a national strategy forthe preventionand management of and research in chronicobstructive pulmonary disease. National Heart, Lung, andBlood Institute Workshop Summary. JAMA 1997;277:246–53
   Google Scholar
• Ferrer M, Alonso J, Morera J, et al. Chronic obstructivepulmonary disease stage and health-related quality of life. AnnIntern Med 1997;127:1072–9
   PubMed Web of Science ®Google Scholar
• Osman LM, Godden DJ, Friend JAR, et al. Quality of life andhospital re-admission in patients with chronic obstructive pulmonarydisease. Thorax 1997;52:67–71
   PubMed Web of Science ®Google Scholar
• Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-relatedquality of life and mortality in male patients with chronicobstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:680–5
   PubMed Web of Science ®Google Scholar
• Halpern MT, Stanford RH, Borker R. The burden of COPD inthe USA: results from the Confronting COPD survey. RespirMed 200;97:S81–9
   Google Scholar
• National Heart Lung and Blood Institute. Morbidity & Mortality: 2004 Chart Book on Cardiovascular, Lung, and Blood Diseases.Bethesda, MD: National Institutes of Health, 2004
   Google Scholar
• Holguin F, Folch E, Redd SC, et al. Comorbidity and mortalityin COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005;128:2005–11
   PubMed Web of Science ®Google Scholar
• Nordyke RJ, Kim JJ, Goldberg GA, et al. Impact of anemia onhospitalization time, charges, and mortality in patients withheart failure. Value Health 2004;7:464–71
   PubMed Web of Science ®Google Scholar
• Lyman GH, Berndt ER, Kallich JD, et al. The economic burdenof anemia in cancer patients receiving chemotherapy. ValueHealth 2005;8:149–56
   Web of Science ®Google Scholar
• Ershler WB, Chen K, Reyes EB, et al. Economic burden of patientswith anemia in selected diseases. Value Health 2005;8:629–38
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. K/DOQI clinical practiceguidelines for anemia of chronic kidney disease, 2000. Am JKidney Dis 2001;37(Suppl 1):S182–238
   PubMedGoogle Scholar
• Silberberg JS, Rahal DP, Patton R, Sniderman AD. Role ofanemia in the pathogenesis of left ventricular hypertrophy inend-stage renal disease. Am J Cardiol 1989;64:222–4
   PubMed Web of Science ®Google Scholar
• Horwich TB, Fonarow GC, Hamilton MA, et al. Anemiais associated with worse symptoms, greater impairment infunctional capacity and a significant increase in mortalityin patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780–6
   PubMed Web of Science ®Google Scholar
• McMurray JJV. What are the clinical consequences ofanemia in patients with chronic heart failure? J Card Fail 2004;10(Suppl):S10–12
   Google Scholar
• Sharma R, Francis DP, Pitt B, et al. Haemoglobin predictssurvival in patients with chronic heart failure: a substudy of theELITE II trial. Eur Heart J 2004;25:1021–8
   PubMed Web of Science ®Google Scholar
• Belperio PS, Rhew DC. Prevalence and outcomes of anemia inindividuals with human immunodeficiency virus: a systematicreview of the literature. Am J Med 2004;116:27–43S
   Google Scholar
• Volberding P. The impact of anemia on quality of life inhuman immunodeficiency virus-infected patients. J Infect Dis 2002;185(Suppl 2):S110–14
   PubMedGoogle Scholar
• Pockros PJ, Shiffman ML, Schiff ER, et al. Epoetin alfaimproves quality of life in anemic HCV-infected patientsreceiving combination therapy. Hepatology 2004;40:1450–8
   PubMed Web of Science ®Google Scholar
• Caro JJ, Salas M, Ward A, Goss G. Anemia as an independentprognostic factor for survival in cancer patients. Cancer 2001;91:2214–21
   PubMed Web of Science ®Google Scholar
• Pennix BW, Pahor M, Cesari M, et al. Anemia is associatedwith disability and decreased physical performance and musclestrength in the elderly. J Am Geriatr Soc 2004;52:719–24
   PubMed Web of Science ®Google Scholar
• Cote C, Zilberberg MD, Mody S, et al. Haemoglobin leveland its clinical impact in a cohort of patients with COPD. EurRespir J 2007;29:923–9
   PubMed Web of Science ®Google Scholar
• Halpern MT, Zilberberg MD, Schmier JK, et al. Anemia, costsand mortality in chronic obstructive pulmonary disease. CostEff Resour Alloc 2006;4:17
   PubMedGoogle Scholar
• Mapel DW, McMillan GP, Frost FJ. Predicting the costs ofmanaging patients with chronic obstructive pulmonary disease.Respir Med 2005;99:1325–33
   Google Scholar
• World Health Organization. Nutritional anemias: report of aWHO scientific group. WHO Technical Report Series 405.Geneva, Switzerland: World Health Organization, 1968:1–37
   Google Scholar
• Kasper DL, Braunwald E, Fauci AS, et al. Anemia andpolycythemia. Harrison’s Online Dictionary. 2005. Availableat http://www3.accessmedicine.com.db.usip.edu/popup.aspx?aID=58150&print=yes. Accessed February 8, 2005
   Google Scholar
• Charlson ME, Pompei P, Ales KL, McKenzie CR. A new methodof classifying prognostic comorbidity in longitudinal studies:development and validation. J Chron Dis 1987;40: 373–83
   PubMedGoogle Scholar
• Anthonisen NR, Wright EC, Hodgkin JE. Prognosis inchronic obstructive pulmonary disease. Am Rev Respir Dis 1986;133:14–20
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the diagnosis and careof patients with chronic obstructive pulmonary disease. Am JRespir Crit Care Med 1995;152(5 pt 2):S77–121
   Google Scholar
• Niewoehner DE, Collins D, Erbland ML, for the Departmentof Veterans Affairs Cooperative Study Group. Relation of FEV1to clinical outcomes during exacerbations of chronic obstructivepulmonary disease. Am J Respir Crit Care Med 2000;161: 1201–5
   Google Scholar
• Pauwels RA, Buist AS, Calverley PMA, et al. Global strategyfor the diagnosis, management, and prevention of chronicobstructive pulmonary disease: NHLBI/WHO Global Initiativefor Chronic Obstructive Lung Disease (GOLD) WorkshopSummary. Am Respir Crit Care Med 2001;163:1256–76
   PubMedGoogle Scholar
• Guralnik JM, Ersshler WB, Schrier SL, et al. Anemia in the elderly:a public health crisis in hematology. Hematology 2005;1:528–32
   Google Scholar
• Krishnan G, Grant BJ, Muti PC, et al. Association betweenanemia and quality of life in a population sample of individualswith chronic obstructive pulmonary disease. BMC Pulm Med 2006;6:23
   PubMedGoogle Scholar
• John M, Hoernig S, Doehner W, et al. Anemia and inflammationin COPD. Chest 2005;127:825–9
   PubMed Web of Science ®Google Scholar
• Chambellan A, Chailleux E, Similowski T, and the ANTADIRObservatory Group. Prognostic value of hematocrit in patientswith severe chronic obstructive pulmonary disease receivinglong term oxygen therapy. Chest 2005;128:1201–8
   Google Scholar
• Jansson SA, Lindbeck A, Ericsson A, et al. Cost differencesfor COPD with and without physician diagnosis. COPD 2005;2:427–34
   PubMedGoogle Scholar